Share on StockTwits

Analysts at Robert W. Baird began coverage on shares of Envision Healthcare Holdings (NASDAQ:EVHC) in a research report issued to clients and investors on Wednesday, TheFlyOnTheWall.com reports. The firm set an “outperform” rating on the stock.

Other equities research analysts have also recently issued reports about the stock. Analysts at Morgan Stanley reiterated a “buy” rating on shares of Envision Healthcare Holdings in a research note on Thursday, June 19th. They now have a $43.00 price target on the stock, up previously from $41.00. Separately, analysts at Goldman Sachs upgraded shares of Envision Healthcare Holdings from a “neutral” rating to a “buy” rating in a research note on Monday, June 16th. They now have a $43.00 price target on the stock, up previously from $36.00. They noted that the move was a valuation call. Finally, analysts at Deutsche Bank reiterated a “buy” rating on shares of Envision Healthcare Holdings in a research note on Tuesday, June 10th. They now have a $37.00 price target on the stock, up previously from $35.00. Two investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $49.47.

Shares of Envision Healthcare Holdings (NASDAQ:EVHC) traded down 2.17% during mid-day trading on Wednesday, hitting $34.68. The stock had a trading volume of 1,379,192 shares. Envision Healthcare Holdings has a one year low of $24.62 and a one year high of $38.02. The stock’s 50-day moving average is $35.53 and its 200-day moving average is $34.01. The company has a market cap of $6.282 billion and a price-to-earnings ratio of 174.63.

Envision Healthcare Holdings (NASDAQ:EVHC) last released its earnings data on Wednesday, May 7th. The company reported $0.20 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.19 by $0.01. The company had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $1.02 billion. During the same quarter in the prior year, the company posted ($0.03) earnings per share. The company’s quarterly revenue was up 14.2% on a year-over-year basis. Analysts expect that Envision Healthcare Holdings will post $1.12 EPS for the current fiscal year.

Envision Healthcare Holdings, Inc, is a provider of physician-led, outsourced medical services in the United States.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.